Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,103 public trials 2,042 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal Impairment

NCT03234335

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Female Urogenital Diseases, +20 more
Locations
  • Centre Pierre et Marie Curie Algiers, Algeria
  • EHU Oran Oran, Algeria
  • CHU Sart Tilman Liège, Belgium
  • Centre Hospitalier Universitaire d'Amiens Amiens, France
View all 33 locations
View Trial Details
Completed

S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia

NCT01925131

Conditions
Acute Leukemias of Ambiguous Lineage, B-cell Adult Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +24 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • University of Rochester Rochester, New York, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
View Trial Details
Completed

FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors

NCT03841110

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +93 more
Locations
  • UCSD Moores Cancer Center San Diego, California, United States
  • University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
  • Hackensack University Medical Center/John Theurer Cancer Center Hackensack, New Jersey, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.

NCT00071084

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Stanford University Med Ctr., Dept of Dermatology Stanford, California, United States
  • University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States
  • Münster, Germany
  • Stockholm, Sweden
View Trial Details
Completed

Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma

NCT01092182

Conditions
Blood-Borne Infections, Burkitt Lymphoma, Communicable Diseases, +29 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Center for Clinical AIDS Research and Education Los Angeles, California, United States
  • Emory University /Winship Cancer Institute Atlanta, Georgia, United States
  • University of Illinois Chicago, Illinois, United States
View all 30 locations
View Trial Details

Related conditions